Details of the Drug

General Information of Drug (ID: DMF4MX9)

Drug Name
Cobomarsen
Synonyms MRG-106
Indication
Disease Entry ICD 11 Status REF
Cutaneous T-cell lymphoma 2B01 Phase 2 [1]
Chronic lymphocytic leukaemia 2A82.0 Phase 1 [2]
Diffuse large B-cell lymphoma 2A81 Phase 1 [2]
Cross-matching ID
PubChem CID
126480232
DrugBank ID
DB14931
TTD ID
D0P9XM
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
microRNA hsa-miR-155 (MIR155) TT1GNRQ NOUNIPROTAC Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03837457) PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study (PRISM). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)